黑料网

ISSN: 2572-0406

Journal of Chemical Biology & Therapeutics
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Aim and Scope

 » Journal of Chemical Biology and Therapeutics is a broad-based journal founded on two key tenets: To publish the most exciting researches related to Chemical Biology: Second to provide a rapid turn-around time possible for reviewing and publishing of articles freely for research, teaching and reference purposes.

 »

It is basically aimed at the Clinical Practitioners, medical/ health practitioners, Pharmaceutical professionals, students, and researchers and professional bodies and institutions.

 »

All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. OJR strongly supports the 黑料网 initiative. All published articles will be assigned DOI provided by Cross Ref. OJR will keep up-to- date with latest advances in the field of Chemical Biology. Abstracts and full texts (HTML, PDF and XML format) of all articles published by OJR are freely accessible to everyone immediately after publication. OJR supports the Bethesda Statement on 黑料网 Publishing.

Definition of 黑料网 Publication

 »

An 黑料网 Publication is one that meets the following two conditions:
 
  • The author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.

  • A complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable Open Access, unrestricted distribution, interoperability, and long-term archiving (for the biomedical sciences, PubMed Central is such a repository).
 » As a member of Publisher International linking Association, PILA, Journal of Chemical Biology and Therapeutics (of OMICS Publishing Group) follows the Creative Commons Attribution License and Scholars 黑料网 publishing policies.

Note:

 »

Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now.
International Conferences 2024-25
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top